Universitätsklinikum Aachen (UKA)

The role of the AC component in human perception of AC–DC hybrid electric fields (2022) Jankowiak K, Kaifie A, Krampert T, Kraus T, Kursawe M Journal article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19 (2022) Singh J, Herrmann I, Mahajan A, Schauer C, Shan X, Hartmann A, Rieker R, et al. Journal article Companion Rescue and Risk Management of Trekkers on the Everest Trek, Solo Khumbu Region, Nepal (2022) Cerfontaine C, Apel C, Bertsch D, Grass M, Haunolder M, Hundt N, Jäger J, et al. Journal article EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy (2022) Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, et al. Journal article Biomechanical evaluation and comparison of clinically relevant versus non-relevant leg length inequalities (2022) Michalik R, Rissel V, Migliorini F, Siebers HL, Betsch M Journal article Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report (2022) von Stillfried S, Bülow RD, Röhrig R, Meybohm P, Boor P, Böcker J, Schmidt J, et al. Journal article Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022) Boehm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, et al. Journal article Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022) Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, et al. Conference contribution Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group (2022) Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, et al. Conference contribution